US is taking a ‘real risk’ with hasty shift in efforts to fight HIV, experts say

Experts warn the US is risking progress against HIV by hastily shifting from Pepfar to fragmented partnerships, citing declining infant testing and concerns over monitoring. The last Pepfar report and the resignation of its chief science officer highlight fears of losing ground as the end of the epidemic nears.